RECRUITING

Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this observational study is to use digital health tracking to improve how high blood pressure and other health issues are detected in pregnant refugee women. The main questions this study aims to answer are are: * Can a digital monitoring system that checks for high blood pressure in these women be tested and refined, using clinical training and validation? * Can this digital monitoring system accurately track any related pregnancy health issues and be used to refer participants to care providers? * Can this system be used to accurately identify risks associated with the contraction of pregnancy-related conditions, such as preeclampsia and high blood pressure? Participants will: * Complete baseline and follow-up in-person appointments; * Complete surveys at these appointment that track their health, stress levels, and comorbidities/risks associated with pregnancy; * Be given a smartwatch fitness tracker and electronic blood pressure cuffs for at-home measurements.

Official Title

Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

Quick Facts

Study Start:2024-09-12
Study Completion:2026-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06647511

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Pregnant
  2. * Refugee, asylum seeking, or asylee as designated by the U.S. Government
  3. * Greater than or equal to 18 years of age
  4. * Has a personal smartphone
  1. * Unable to provide informed consent
  2. * Determined by the PI to be in an extremely vulnerable position and therefore not suited for research participation
  3. * Planned move from the New York City (NYC) area within the next 24 months

Contacts and Locations

Study Contact

Gunisha Kaur, MA, MD
CONTACT
(212) 746-2461
gus2004@med.cornell.edu
Michele Steinkamp, RN
CONTACT
2127462953
mls9004@med.cornell.edu

Principal Investigator

Gunisha Kaur, MA, MD
PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University

Study Locations (Sites)

Weill Cornell Medicine
New York, New York, 10065
United States

Collaborators and Investigators

Sponsor: Weill Medical College of Cornell University

  • Gunisha Kaur, MA, MD, PRINCIPAL_INVESTIGATOR, Weill Medical College of Cornell University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-12
Study Completion Date2026-09

Study Record Updates

Study Start Date2024-09-12
Study Completion Date2026-09

Terms related to this study

Keywords Provided by Researchers

  • refugee
  • pregnant
  • digital

Additional Relevant MeSH Terms

  • Gestational Hypertension